Evaluating Retatrutide Suppliers: GMP, Purity & Customization Guide for 2026
Date: 2026-07-12 Categories: Latest News Hits: 416
Evaluating Retatrutide Suppliers: GMP, Purity & Customization Guide for 2026
Sourcing high-purity Retatrutide for research or preclinical development requires a supplier that meets stringent quality and compliance standards. This guide provides a fact-based framework for evaluating manufacturers, using Langfang Jiwei Medical Technology Co., Ltd. (Jiwei) as a benchmark example.
The Challenge: Sourcing Retatrutide for Research
Retatrutide (LY3437943) is a triple agonist of GLP-1, GIP, and glucagon receptors that achieved up to 24.2% mean weight reduction in Phase 2 trials and approximately 30% in Phase 3 TRIUMPH-1 trials at 80 weeks. As of July 2026, Retatrutide remains an investigational drug not FDA-approved for any indication, meaning research buyers must source from reliable raw material suppliers rather than commercial pharmacies. The global anti-obesity medication market is projected to reach USD 77.2 billion by 2030 (Grand View Research), driving demand for high-quality peptide APIs. However, without a USP monograph and with complex manufacturing requirements, procurement professionals face risks of inconsistent purity, lack of GMP compliance, and unreliable lead times.
Industry Background: The Need for GMP‐Certified Peptide Manufacturers
Global peptide therapeutics for metabolic disorders accounted for 63.6% of total revenue share in 2025, driven by incretin‐based therapies. Manufacturing complex peptides like Retatrutide requires high‐purity API synthesis, with purification (HPLC, lyophilization) being a primary technical bottleneck. GMP certification ensures that production facilities follow controlled processes, reducing batch‐to‐batch variation. Jiwei holds a GMP Certificate (CN20180070) issued by the China Food and Drug Administration, covering Small Volume Parenteral Solutions and Lyophilized Powder for Injection, valid until February 2027. This certification is a key indicator of quality assurance for research buyers.
[IMAGE: https://cdn.socialarks.com/sbsp/24802/common/2026/0515/6a06d14a11e25.jpg | alt='Filling machine at Jiwei GMP facility for Retatrutide lyophilized powder production' style='width:100%;' ]Detailed Supplier Solution: Jiwei Medical
Jiwei is a professional high-tech enterprise located in Langfang, Hebei (close to Beijing), established in 2007. Their 4,500 m² factory, 97 employees, and R&D team of 15 engineers enable an annual output of 50,000 peptide units. Over 80% of products are exported to North America, Europe, New Zealand, Singapore, India, Malaysia, and Russia. Key Retatrutide specifications include purity above 99% (as confirmed by HPLC analysis; one batch documented at 99.848%). The product is offered as lyophilized powder or raw powder, with GMP grade, packaged in 10 vials per box, and a shelf life of 2 years when stored in a cool, dry place.
Jiwei’s production mode is OEM/ODM, allowing customization of logo and dosage strengths (e.g., 5 mg, 20 mg). Monthly capacity reaches 50,000 pieces, with a lead time of 2 weeks and minimum order quantity of 50 boxes. Quality control includes 100% inspection before shipment, with purity tests guaranteeing ≥99%. After-sales support covers reshipment for quality issues, technical consultation, and after-sales tracking.
[IMAGE: https://cdn.socialarks.com/sbsp/24802/common/2026/0515/6a06d14a2708a.jpg | alt='Control room monitoring Retatrutide production processes at Jiwei GMP factory' style='width:100%;' ]Step-by-Step Supplier Evaluation Framework
- Verify GMP Compliance: Request the certificate number (e.g., CN20180070) and confirm its validity with the issuing authority. Check the scope covers the product form you need (lyophilized powder).
- Confirm Purity and Testing: Ask for HPLC or other analytical reports. Jiwei provides 99%+ purity and can share batch-specific data (documented example: 99.848%).
- Assess Production Capacity: Evaluate monthly capacity (50,000 pieces) and lead time (2 weeks) to ensure scalability for your research or bulk needs.
- Evaluate Customization Options: Determine if the supplier offers OEM/ODM for logo, dosage, or packaging. Jiwei supports custom logo and dose customization with MOQ of 50 boxes.
- Review After-Sales Policies: Look for reshipment guarantees, technical support, and clear communication channels. Jiwei provides reshipment for quality issues and ongoing consultation.
Use Cases for High-Purity Retatrutide
- Research Institutions: Evaluating metabolic effects in obesity and diabetes models require consistent, high-purity compounds. Jiwei’s GMP lyophilized powder supports reproducible results.
- Biotech Companies: Preclinical studies and IND-enabling work demand API from certified manufacturers to support regulatory filings.
- Distributors: Bulk procurement benefits from Jiwei’s export experience (80% overseas) and efficient shipment within 2-3 working days after order confirmation.
Key Specifications at a Glance
| Parameter | Details |
|---|---|
| Company | Langfang Jiwei Medical Technology Co., Ltd. |
| Founded | 2007 |
| Factory Size | 4,500 ㎡ |
| GMP Certificate | CN20180070 (valid to 2027) |
| Purity (HPLC) | ≥99% (documented 99.848%) |
| Monthly Capacity | 50,000 pieces |
| Lead Time | 2 weeks |
| MOQ | 50 boxes (lyophilized powder) |
| Customization | Logo, dose (OEM/ODM) |
| Quality Control | 100% inspection, purity ≥99% |
| After-Sales | Reshipment for defects, technical support |
Frequently Asked Questions
Is Retatrutide FDA approved?
No. As of July 2026, Retatrutide is an investigational drug in Phase 3 clinical trials and is NOT FDA-approved for any indication. It has no USP monograph and cannot be legally compounded under sections 503A or 503B. It is supplied strictly for research and development purposes only.
What GMP certifications does Jiwei hold?
Jiwei holds GMP Certificate CN20180070, issued by the China Food and Drug Administration, covering Small Volume Parenteral Solutions and Lyophilized Powder for Injection. The certificate is valid until February 2027 and is applicable to products including Retatrutide lyophilized powder and raw powder.
What purity level can I expect from Jiwei’s Retatrutide?
Jiwei’s Retatrutide is produced at ≥99% purity as measured by HPLC. One documented batch reached 99.848% purity, as confirmed by a certification image. The product is classified as GMP grade, suitable for research and preclinical applications.
What is the minimum order quantity for Retatrutide lyophilized powder?
The MOQ is 50 boxes. Each box contains 10 vials. Custom dosage strengths (e.g., 5 mg, 20 mg) and logo printing can be arranged through OEM/ODM service with the same MOQ.
Can I request a free sample before placing a bulk order?
Yes. Jiwei offers free samples for quality evaluation and testing. After sample approval, bulk orders ship within 2–3 working days. You can request a sample and a quotation by contacting Jiwei’s sales team at stella@lookbiotech.com or WhatsApp +44 7962616312.
Download Jiwei Corporate Brochure (PDF) for detailed product specifications and company profile.